Global Prolastin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prolastin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Prolastin injection, also called alpha 1-PI, is used to treat a certain type of emphysema (a lung condition). The emphysema is caused by the lack of a protein called alpha 1-antitrypsin (AAT) in the body.
Prolastin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prolastin market is projected to reach US$ 540.9 million in 2029, increasing from US$ 356 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The Prolastin market is driven by the increasing prevalence of Alpha-1 Antitrypsin Deficiency (AATD), a genetic disorder that leads to lung and liver diseases. Prolastin, a medication containing alpha-1 antitrypsin protein, is used to treat AATD by supplementing the deficient protein levels and reducing the risk of lung damage. The drug's efficacy in slowing disease progression and improving patient outcomes has contributed to its growing adoption among AATD patients. Moreover, advancements in diagnostic methods and increased awareness of AATD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Prolastin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prolastin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Grifols
Segment by Type
20ml
40ml
Hospital
Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prolastin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prolastin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prolastin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prolastin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prolastin introduction, etc. Prolastin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prolastin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Prolastin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prolastin market is projected to reach US$ 540.9 million in 2029, increasing from US$ 356 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The Prolastin market is driven by the increasing prevalence of Alpha-1 Antitrypsin Deficiency (AATD), a genetic disorder that leads to lung and liver diseases. Prolastin, a medication containing alpha-1 antitrypsin protein, is used to treat AATD by supplementing the deficient protein levels and reducing the risk of lung damage. The drug's efficacy in slowing disease progression and improving patient outcomes has contributed to its growing adoption among AATD patients. Moreover, advancements in diagnostic methods and increased awareness of AATD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Prolastin market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prolastin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Grifols
Segment by Type
20ml
40ml
Segment by Application
Hospital
Pharmacy
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prolastin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prolastin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prolastin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prolastin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prolastin introduction, etc. Prolastin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prolastin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices